SCHEMBL16975162

SCHEMBL16975162

CCOCC(CC(Cc1ccc(-c2cc(Cl)ccc2F)cc1)NC(=O)c1cc(CC)no1)C(=O)O

nearest known ligand 0.76

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 19/20 0.76
▸ MMEL1 Q495T6 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16930657 1.00 MME (0.76) MMEMMEL1
SCHEMBL16930440 0.93 MME (0.77) MMEMMEL1
SCHEMBL16930484 0.91 MME (0.72) MMEMMEL1
SCHEMBL16930576 0.90 MME (0.82) MMEMMEL1
SCHEMBL20306306 0.89 MME (0.76) MMEMMEL1
SCHEMBL16941055 0.88 MME (0.75) MMEMMEL1
SCHEMBL16939251 0.87 MME (0.70) MMEMMEL1
SCHEMBL16930532 0.86 MME (1.00) MMEMMEL1
SCHEMBL20280996 0.85 MME (0.77) MMEMMEL1
SCHEMBL16930601 0.85 MME (0.77) MMEMMEL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3099678-A1 NEPRILYSIN INHIBITORS Theravance Biopharma R&D IP, LLC (US) 2016-12-07 — — EP disclosed
WO-2015116786-A1 NEPRILYSIN INHIBITORS THERAVANCE BIOPHARMA R&D IP, LLC (US) 2015-08-06 — — WO disclosed
Send feedback